Effects of the PPAR-gamma Agonist Pioglitazone on Renal and Hormonal Responses to Salt in Diabetic and Hypertensive Subjects.
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2011
At a glance
- Drugs Pioglitazone (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 13 Jul 2011 Results published in the Journal of Clinical Endocrinology and Metabolism.
- 23 Apr 2010 Results have been published (Diabetologia: 23 Apr 2010).
- 09 Apr 2010 Additional lead trial centre (University of Lausanne Hospitals) added as reproted by ClinicalTrials.gov record.